Eric Swayze is EVP Research of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 48,017 shares of IONS, which is worth approximately $1.57 Million. The most recent transaction as insider was on Feb 26, 2021, when has been sold 460 shares (Common Stock) at a price of $44.54 per share, resulting in proceeds of $20,488. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48K
37.56% 3M change
39.89% 12M change
Total Value Held $1.57 Million

Eric Swayze Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 26 2021
BUY
Other acquisition or disposition
$20,488 $44.54 p/Share
460 Added 3.91%
11,295 Common Stock
Jan 15 2021
SELL
Payment of exercise price or tax liability
$197,076 $61.28 p/Share
3,216 Reduced 22.89%
10,835 Common Stock
Jan 15 2021
BUY
Exercise of conversion of derivative security
-
8,944 Added 38.9%
14,051 Common Stock
Jan 05 2021
SELL
Open market or private sale
$10,918 $55.99 p/Share
195 Reduced 3.68%
5,107 Common Stock
ES

Eric Swayze

EVP Research
Carlsbad, CA

Track Institutional and Insider Activities on IONS

Follow IONIS PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

News

Receive news related to IONIS PHARMACEUTICALS INC

Track Activities on IONS